CoChat

The Impact of Glucocorticoid Replacement on Bone Mineral Density in Patients With Hypopituitarism Before and After 2 Years of Growth Hormone Replacement Therapy

Ragnar Agnarsson, Hjalmar, Johannsson, Gudmundur, Ragnarsson, Oskar · 2014 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Abstract

CONTEXT: Patients with hypopituitarism have reduced bone mineral density (BMD) and increased fracture risk. OBJECTIVE: The aim of this study was to analyze the effects of glucocorticoid (GC) replacement on BMD before and after 2 years of GH therapy in hypopituitary patients. The main hypothesis was that patients on GC replacement demonstrate greater improvement in BMD when treated with GH. DESIGN: This was a post hoc analysis of data from a prospective single-center study. PATIENTS: Data on 175 adult patients with hypopituitarism and verified GH deficiency due to nonfunctioning pituitary adenoma were analyzed. Ninety-eight (56%) were GC insufficient, receiving a mean ± SD hydrocortisone equivalent dose of 20.9 ± 5.0 mg/d. MAIN OUTCOME MEASURE: BMD before and after 2 years of GH replacement therapy was measured by using dual-energy X-ray absorptiometry. RESULTS: BMD at baseline did not differ between GC-sufficient and -insufficient patients, neither at lumbar spine nor femur neck. After 2 years on GH replacement, BMD increased in both groups. After adjustment for weight, age, gender, free T4 concentrations, change in IGF-I levels, and sex hormone treatment, GC sufficiency was associated with a greater increase in BMD at the femur neck (ΔT-score in GC insufficient patients 0.09 ± 0.46, in GC sufficient patients 0.19 ± 0.43; P < .05) but not at the lumbar spine. CONCLUSIONS: GH replacement therapy for 2 years increased BMD in hypopituitary patients. In contrast to our hypothesis, GC-insufficient patients receiving near physiological doses of hydrocortisone do not show a greater therapeutic response to GH therapy than their GC-sufficient counterparts.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2013-3851

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Cited by

See all 10

Metadata

Authors
Ragnar Agnarsson, H., Johannsson, G., & Ragnarsson, O.
Affiliations
  • Faculty of Medicine (H.R.A.), University of Iceland, 101 Reykjavik Iceland
  • University of Gothenburg (SE)
  • Institute of Medicine (G.J., O.R.), Sahlgrenska Academy, University of Gothenburg, SE-413 45 Göteborg Sweden
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2014-04-01
Volume
99
Issue
4
Pages
1479-1485
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2042131849
Cited by
10
References
35
Citations by year
2025: 1 · 2024: 2 · 2022: 1 · 2020: 1 · 2018: 2 · 2016: 1 · 2015: 1 · 2014: 1
FWCI
0.80
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
hypopituitarism, growth hormone replacement therapy, glucocorticoid replacement therapy, bone mineral density, cortisol, glucocorticoid insufficiency, non-functioning pituitary adenoma, fracture risk, femoral neck, lumbar spine, insulin-like growth factor I
MeSH terms
Adenoma, Adult, Aged, Female, Glucocorticoids, Humans, Hypopituitarism, Longitudinal Studies, Male, Middle Aged, Pituitary Neoplasms, Retrospective Studies, Bone Density, Human Growth Hormone, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Impact of Glucocorticoid Replacement on Bone Mineral Density in Patients With Hypopituitarism Before and After 2 Years of Growth Hormone Replacement Therapy. https://app.cochat.ai/papers/10.1210/jc.2013-3851
The paper
Ragnar Agnarsson, H., Johannsson, G., & Ragnarsson, O. (2014). The Impact of Glucocorticoid Replacement on Bone Mineral Density in Patients With Hypopituitarism Before and After 2 Years of Growth Hormone Replacement Therapy. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2013-3851

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.